BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2392748)

  • 1. [Quantitative changes of the blood serum immunoglobulins in patients with diabetes mellitus types I and II and microangiopathy detected by morphologic study].
    Saltykov BB; Velikov VK; Tarasov VK; Pershin BB; Kuz'min SN; Shubina OI; Frolova AI; Zelenchuk NM; Shepkova TP
    Ter Arkh; 1990; 62(4):111-4. PubMed ID: 2392748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Participation of immune mechanisms in the development of microangiopathies in patients with non-insulin-dependent diabetes mellitus].
    Saltykov BB; Velikov VK; Shubina OI; Frolova AI; Pershin BB
    Arkh Patol; 1986; 48(5):16-21. PubMed ID: 3741172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomorphological study of diabetic microangiopathy].
    Saltykov BB; Velikov VK
    Arkh Patol; 2000; 62(2):5-9. PubMed ID: 10789005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of microangiopathy in insulin-dependent diabetes mellitus (data from the morphological examination of skin biopsy specimens)].
    Saltykov BB; Velikov VK; Shubina OI; Zelenchuk NM
    Arkh Patol; 1986; 48(2):47-51. PubMed ID: 3707390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum C4 concentration, diabetes mellitus and diabetic microangiopathy].
    Costa B; Belmonte MA; Callizo J; Pastor RM; Huguet R; Richart C
    Med Clin (Barc); 1988 Dec; 91(19):728-31. PubMed ID: 3236916
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic mechanisms of the pathogenesis of microangiopathy in insulin-dependent diabetes mellitus].
    Saltykov BB; Velikov VK; Shubina OI; Frolova AI; Pershin BB
    Sov Med; 1987; (9):14-7. PubMed ID: 3423981
    [No Abstract]   [Full Text] [Related]  

  • 7. Not only quantitative but also qualitative changes of serum immunoglobulins in diabetes mellitus.
    Cheţa D; Manciulea M; Sântu E; Georgescu M; Perciun R; Sulica A; Mincu I
    Rom J Intern Med; 1991; 29(3-4):181-7. PubMed ID: 1784947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic microangiopathy (based on the morphological study data from skin biopsies)].
    Saltykov BB
    Arkh Patol; 1981; 43(3):42-7. PubMed ID: 7236031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamic morphologic follow-up of diabetic microangiopathy].
    Saltykov BB; Velikov VK
    Arkh Patol; 2000; 62(6):42-6. PubMed ID: 11198122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphogenesis of diabetic microangiopathy].
    Saltykov BB; Kaufman OIa; Velikov VK; Shubina OI
    Arkh Patol; 1991; 53(7):60-5. PubMed ID: 1741670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Status of cellular immunity in diabetic microangiopathy detected by skin biopsy].
    Ermakova NG; Saltykov BB; Velikov VK; Shubina OI; Frolova AI
    Ter Arkh; 1986; 58(10):94-7. PubMed ID: 3492060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus.
    Triolo G; Giardina E; Seddio G; Terrizzi C
    Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A semi quantitative approach to diabetic microangiopathy. Study of the relationship between the duration of the diabetes and the intensity of the microangiopathy].
    Romani JD
    Nouv Presse Med; 1973 Dec; 2(45):3037-9. PubMed ID: 4775191
    [No Abstract]   [Full Text] [Related]  

  • 14. [The relationship between concentration of growth hormone in serum and microangiopathy in patients with diabetes mellitus].
    Chen M; Yu W; Hu S
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):765-7. PubMed ID: 9772523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C4 concentration and diabetic microangiopathy in insulin dependent diabetes. A study of an Italian group of insulin dependent diabetic patients.
    Altomonte L; Zoli A; Mirone L; Mangia A; Masucci M; Ghirlanda G; Greco AV
    Panminerva Med; 1987; 29(4):307-10. PubMed ID: 3431891
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of antiaggregants on the course of diabetic microangiopathy].
    Bokarev IN; Velikov VK; Zelenchuk NM; Shubina OI; Saltykov BB; Frolova AI; Polunin GS; Pirogova EP; Nikol'skaia VV; Davydova NG
    Ter Arkh; 1993; 65(3):78-81. PubMed ID: 8059393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immunological aspects of the development of diabetes mellitus and its complications].
    Kamaeva OI
    Ter Arkh; 1994; 66(10):14-7. PubMed ID: 7863435
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoglobulins and diabetic microangiopathy].
    Vakov L
    Vutr Boles; 1985; 24(3):94-8. PubMed ID: 4024628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.